Compelo - latest news, features and insight on influencers and innovators within business is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

J&J loses $110M cancer link claim in yet another shocking lawsuit

The recent verdict where J&J loses $110M cancer link claim comes amidst thousands of other similar allegations.

Johnson & Johnson (J&J) is an American maker of pharmaceutical, medical devices, and other consumer goods. Furthermore, its international presence positions it as a provider of baby-friendly hygiene products.

However, a recent multi-million dollar lawsuit positions the historic company for potentially devastating losses.

A Missouri jury ordered a verdict that J&J pay long time consumer Lois Slemp over $110mn in compensation. Slemp used J&J’s Baby Powder and Shower to Shower Powder for over forty years. In 2012 her diagnosis spread to include her liver.

Consequently, she claims that their feminine hygiene talc products caused her to develop ovarian cancer.

As such, Slemp argues that Imerys Talc, the company that provides J&J with the product, should also be held accountable. She maintains asbestos is a contaminant of the Imerys Talc merchandise.

J&J loses $110M cancer link claim - Compelo
Flickr/Austin Kirk

J&J loses $110M cancer link claim: Slemp not alone

Yet, Lois Slemp isn’t the only person to come forward with this shocking allegation.

The corporation’s recent health scare comes amidst accusations from other victims that J&J utilises carcinogenics in its products.

Furthermore, there are 2,400 other accusations of J&J of failing to warn consumers of the cancer-risks in their talc products.

Also, Slemp’s lawyer, Ted Meadows heavily criticised the lack of social responsibility shown by J&J and Imerys Talc.

“Once again we’ve shown that these companies ignored the scientific evidence, and continue to deny responsibilities to the women of America.”

J&J loses $110M cancer link claim - Compelo
Wikimedia Commons/Luis García

Meadows also represents additional plaintiffs with health allegations against the companies in question.

However, J&J maintains that there are no links between their products and cancer.

“We are preparing for additional trials this year and we continue to defend the safety of Johnson’s Baby Powder,” J&J said in a statement.

Additionally, it plans to appeal the Slemp trial, plus a string of other losses that began in February 2016.

Read more:

British businesses will lose billions if the Queen dies

Facebook gender bias: Is Sandberg the token female?

“The banking industry is ripe for change”: Fintech and the rise of challenger banks